Skip to main content
Figure 5 | SpringerPlus

Figure 5

From: LAP degradation product reflects plasma kallikrein-dependent TGF-β activation in patients with hepatic fibrosis

Figure 5

Control experiments for immunostaining with R58 and L59 antibodies. Serial liver sections of from CCl4-treated mice at 12 weeks were stained with R58 antibody (1 μg/ml) (a), R58 antibody (1 μg/ml) that had been pre-incubated with 10 μg/ml R58 antigen peptide (b), the same concentration of nonimmune mouse IgG (c), and L59 antibody (1 μg/ml) (d). Scale bars = 25 μm. This picture shows the representative result from three independent experiments.

Back to article page